InfraReDx

About:

InfraReDx designs and develops intelligent catheter-based coronary imaging devices.

Website: http://www.infraredx.com

Top Investors: GE Capital, Nipro Corporation, Sanderling Ventures, Difference Capital

Description:

InfraReDx, Inc. designs, develops, manufactures, and distributes medical devices. The company specializes in near-infrared spectroscopic (NIRS) technology and its application to coronary imaging. It develops a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify and characterize vulnerable plaque in the coronary arteries. The company was founded in 1998 and is headquartered in Burlington, Massachusetts.

Total Funding Amount:

$118M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Burlington, Massachusetts, United States

Founded Date:

1998-01-01

Contact Email:

info(AT)infraredx.com

Founders:

James E. Muller

Number of Employees:

51-100

Last Funding Date:

2013-08-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai